Astex Pharma shareholder opposes $886 mil bid by Otsuka

This is great news for Otsuka. With debt ceiling debacle,most US corporate shares will plunge so Otsuka should back away for now. No need to pay top dollars for something they can buy cheaper. Watch the greedy hedge fund & shareholders come back with their tails between their legs begging for them to buy their company. Japanese companies have to play smart. Buying low & selling high should be their business mantra. They should have learned this lesson 20 years ago!